Femara (Letrozole) was developed for treatment of breast cancer in post menopausal women. It is a Type II Aromatase Inhibitor which means that it binds with aromatase enzyme completely thus making it incapable of converting steroids to estrogen. It reduces estrogen level in women with breast cancer by almost 98% or even more. Athletes use this drug to inhibit aromatisation which arises because of other anabolic steroid taken. Hence the vicious estrogenic effects like water retention and fat gain can be overcome. Letrozole is a powerful drug and a small dose like .25-.5mg per day is also effective is getting desired results.
0 comments:
Post a Comment